Humana (NYSE:HUM) Raised to Strong-Buy at Wolfe Research

Humana (NYSE:HUM) was upgraded by research analysts at Wolfe Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

A number of other equities analysts have also weighed in on the stock. Barclays upped their price target on shares of Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 26th. Raymond James Financial reiterated an “outperform” rating and issued a $260.00 price target on shares of Humana in a research report on Friday, May 1st. Mizuho upped their price target on shares of Humana from $290.00 to $335.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 20th. Cantor Fitzgerald started coverage on shares of Humana in a research report on Wednesday, May 20th. They issued an “overweight” rating for the company. Finally, Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, fourteen have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $279.30.

Humana Stock Performance

HUM opened at $349.87 on Thursday. The firm has a market cap of $42.01 billion, a P/E ratio of 37.42, a PEG ratio of 1.87 and a beta of 0.76. Humana has a 1-year low of $163.11 and a 1-year high of $351.88. The company has a 50 day simple moving average of $244.92 and a two-hundred day simple moving average of $231.58. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s revenue was up 23.5% on a year-over-year basis. During the same period in the prior year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts forecast that Humana will post 9 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Humana

A number of hedge funds and other institutional investors have recently modified their holdings of HUM. Montag A & Associates Inc. raised its stake in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC raised its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac purchased a new stake in Humana during the fourth quarter valued at $27,000. Reflection Asset Management purchased a new stake in Humana during the fourth quarter valued at $29,000. Finally, Rosenberg Matthew Hamilton raised its stake in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.